Business ❯ Corporate Strategy ❯ Market Expansion
Bang Energy Tilray Brands Growth Opportunities Drug Development Healthcare Sector Sustainability Initiatives Industry Leaders Financial Investments Regulatory Approval
The purchase marks Pfizer’s pivot toward cardiometabolic drugs following setbacks in its oral GLP‑1 program.
